Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)
CAPS Rating:
A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.
RSS Headlines
Fool UK
Recs
Cytori Therapeutics is inmerse in a big moment right now. Their bussines is going to get huge as there is a big market for the stem cells applied to heart recovery after heart atacks and also for the breasts surgery.